1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HIV-1	HIV-1	_	_	_	_	_	_	_
4	replication	replication	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	combination	combination	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	novel	novel	_	_	_	_	_	_	_
10	inhibitor	inhibitor	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	AZT	AZT	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	small	small	_	_	_	_	_	_	_
3	molecule	molecule	_	_	_	_	_	_	_
4	S9a	S9a	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	derived	derive	_	_	_	_	_	_	_
7	from	from	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	established	establish	_	_	_	_	_	_	_
10	tumor	tumor	_	_	_	_	_	_	_
11	necrosis	necrosis	_	_	_	_	_	_	_
12	factor-alpha	factor-alpha	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	inhibitor	inhibitor	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	Canventol	Canventol	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	replacement	replacement	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	isopropylidine	isopropylidine	_	_	_	_	_	_	_
25	group	group	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	phenyl	phenyl	_	_	_	_	_	_	_
29	ring	ring	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	S9a	S9a	_	_	_	_	_	_	_
2	at	at	_	_	_	_	_	_	_
3	10	10	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	100	100	_	_	_	_	_	_	_
6	nM	nM	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	HIV	HIV	_	_	_	_	_	_	_
9	production	production	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	potently	potently	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	3’-azido-3’-deoxythymidine	3'-azido-3'-deoxythymidine	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	AZT	AZT	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	an	an	_	_	_	_	_	_	_
19	inhibitor	inhibitor	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	viral	viral	_	_	_	_	_	_	_
22	reverse	reverse	_	_	_	_	_	_	_
23	transcriptase	transcriptase	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	S9a	S9a	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	AZT	AZT	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	combination	combination	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	noncytoxic	noncytoxic	_	_	_	_	_	_	_
11	concentrations	concentration	_	_	_	_	_	_	_
12	strongly	strongly	_	_	_	_	_	_	_
13	inhibited	inhibit	_	_	_	_	_	_	_
14	HIV-1	HIV-1	_	_	_	_	_	_	_
15	replication	replication	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	more	more	_	_	_	_	_	_	_
19	than	than	_	_	_	_	_	_	_
20	additive	additive	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	substantially	substantially	_	_	_	_	_	_	_
23	prolonged	prolong	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	appearance	appearance	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	virus	virus	_	_	_	_	_	_	_
28	both	both	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	acutely	acutely	_	_	_	_	_	_	_
31	infected	infected	_	_	_	_	_	_	_
32	CD4+	cd4+	_	_	_	_	_	_	_
33	lymphocytes	lymphocyte	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	SupT	SupT	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	culture	culture	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	in	in	_	_	_	_	_	_	_
41	peripheral	peripheral	_	_	_	_	_	_	_
42	blood	blood	_	_	_	_	_	_	_
43	mononuclear	mononuclear	_	_	_	_	_	_	_
44	cells	cell	_	_	_	_	_	_	_
45	(	(	_	_	_	_	_	_	_
46	PBMCs	PBMC	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	infected	infect	_	_	_	_	_	_	_
49	with	with	_	_	_	_	_	_	_
50	a	a	_	_	_	_	_	_	_
51	primary	primary	_	_	_	_	_	_	_
52	HIV-1	HIV-1	_	_	_	_	_	_	_
53	isolate	isolate	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	S9a	S9a	_	_	_	_	_	_	_
2	inhibited	inhibit	_	_	_	_	_	_	_
3	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
4	promoter-driven	promoter-driven	_	_	_	_	_	_	_
5	reporter	reporter	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	proposed	propose	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	mechanism	mechanism	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	antiviral	antiviral	_	_	_	_	_	_	_
9	action	action	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	S9a	S9a	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	on	on	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	host	host	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	blocking	block	_	_	_	_	_	_	_
20	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
21	transcription	transcription	_	_	_	_	_	_	_
22	via	via	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	Tat-induced	tat-induced	_	_	_	_	_	_	_
25	tar-independent	tar-independent	_	_	_	_	_	_	_
26	loop	loop	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	which	which	_	_	_	_	_	_	_
29	decreases	decrease	_	_	_	_	_	_	_
30	downstream	downstream	_	_	_	_	_	_	_
31	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
32	activation	activation	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	HIV-1	HIV-1	_	_	_	_	_	_	_
35	long	long	_	_	_	_	_	_	_
36	terminal	terminal	_	_	_	_	_	_	_
37	repeat	repeat	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	LTR	LTR	_	_	_	_	_	_	_
40	)	)	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	S9a	S9a	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	superior	superior	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	first	first	_	_	_	_	_	_	_
7	generation	generation	_	_	_	_	_	_	_
8	compound	compound	_	_	_	_	_	_	_
9	Canventol	Canventol	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	superior	superior	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	natural	natural	_	_	_	_	_	_	_
17	compound	compound	_	_	_	_	_	_	_
18	sarcophytol	sarcophytol	_	_	_	_	_	_	_
19	A	a	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	demonstrating	demonstrate	_	_	_	_	_	_	_
22	that	that	_	_	_	_	_	_	_
23	further	further	_	_	_	_	_	_	_
24	structure-based	structure-based	_	_	_	_	_	_	_
25	enhancement	enhancement	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	potency	potency	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	these	these	_	_	_	_	_	_	_
30	compounds	compound	_	_	_	_	_	_	_
31	is	be	_	_	_	_	_	_	_
32	feasible	feasible	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	suggests	suggest	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	therapeutic	therapeutic	_	_	_	_	_	_	_
6	approach	approach	_	_	_	_	_	_	_
7	against	against	_	_	_	_	_	_	_
8	AIDS	AIDS	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	application	application	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	two	two	_	_	_	_	_	_	_
13	drugs	drug	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	one	one	_	_	_	_	_	_	_
16	against	against	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	cellular	cellular	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	other	other	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	viral	viral	_	_	_	_	_	_	_
24	target	target	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	which	which	_	_	_	_	_	_	_
27	may	may	_	_	_	_	_	_	_
28	provide	provide	_	_	_	_	_	_	_
29	an	an	_	_	_	_	_	_	_
30	approach	approach	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	problem	problem	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	frequent	frequent	_	_	_	_	_	_	_
36	emergence	emergence	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	resistant	resistant	_	_	_	_	_	_	_
39	variants	variant	_	_	_	_	_	_	_
40	to	to	_	_	_	_	_	_	_
41	combinations	combination	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	drugs	drug	_	_	_	_	_	_	_
44	that	that	_	_	_	_	_	_	_
45	target	target	_	_	_	_	_	_	_
46	only	only	_	_	_	_	_	_	_
47	HIV	HIV	_	_	_	_	_	_	_
48	genes	gene	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

